ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 244 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $4,204,777 | +13.9% | 137,411 | 0.0% | 0.34% | -15.1% |
Q3 2023 | $3,692,234 | -24.6% | 137,411 | 0.0% | 0.40% | +19.8% |
Q2 2023 | $4,900,076 | +40.4% | 137,411 | 0.0% | 0.34% | +39.7% |
Q1 2023 | $3,490,239 | +62527.7% | 137,411 | 0.0% | 0.24% | -62.3% |
Q4 2022 | $5,573 | -99.9% | 137,411 | 0.0% | 0.64% | +28.1% |
Q3 2022 | $4,541,000 | -6.1% | 137,411 | 0.0% | 0.50% | +3.1% |
Q2 2022 | $4,838,000 | -23.4% | 137,411 | 0.0% | 0.49% | +11.7% |
Q1 2022 | $6,320,000 | -30.6% | 137,411 | 0.0% | 0.44% | -20.8% |
Q4 2021 | $9,110,000 | +6.2% | 137,411 | 0.0% | 0.55% | +42.6% |
Q3 2021 | $8,579,000 | -24.6% | 137,411 | 0.0% | 0.38% | -21.9% |
Q2 2021 | $11,380,000 | +24.9% | 137,411 | 0.0% | 0.49% | +54.1% |
Q1 2021 | $9,112,000 | -42.1% | 137,411 | -33.0% | 0.32% | -54.4% |
Q4 2020 | $15,737,000 | -36.6% | 205,091 | -64.4% | 0.70% | -51.1% |
Q3 2020 | $24,824,000 | -0.3% | 576,505 | 0.0% | 1.44% | -19.6% |
Q2 2020 | $24,899,000 | +12.6% | 576,505 | -25.0% | 1.78% | -10.9% |
Q1 2020 | $22,115,000 | -69.8% | 768,674 | -72.2% | 2.00% | -70.8% |
Q2 2019 | $73,277,000 | +71.5% | 2,765,153 | +18.8% | 6.87% | +61.2% |
Q1 2019 | $42,728,000 | +47.7% | 2,328,475 | 0.0% | 4.26% | +15.4% |
Q4 2018 | $28,920,000 | -35.2% | 2,328,475 | 0.0% | 3.69% | -17.9% |
Q3 2018 | $44,637,000 | +72.7% | 2,328,475 | +22.6% | 4.50% | +35.1% |
Q2 2018 | $25,840,000 | +88.6% | 1,900,000 | 0.0% | 3.33% | +71.6% |
Q1 2018 | $13,699,000 | – | 1,900,000 | – | 1.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $93,815,000 | 51.06% |
Aquilo Capital Management, LLC | 436,514 | $12,559,000 | 4.90% |
Vivo Capital, LLC | 768,674 | $22,115,000 | 2.00% |
ACUTA CAPITAL PARTNERS, LLC | 109,700 | $3,156,000 | 1.53% |
Prosight Management, LP | 104,737 | $3,013,000 | 1.41% |
Capital Impact Advisors, LLC | 84,537 | $2,432,000 | 1.02% |
Artal Group S.A. | 600,000 | $17,262,000 | 0.73% |
HUSSMAN STRATEGIC ADVISORS, INC. | 62,000 | $1,784,000 | 0.48% |
Quantitative Investment Management, LLC | 150,401 | $4,327,000 | 0.47% |
OAK RIDGE INVESTMENTS LLC | 131,502 | $3,784,000 | 0.39% |